Safety
213
26
32
112
Key Insights
Highlights
Success Rate
93% trial completion (above average)
Published Results
24 trials with published results (11%)
Research Maturity
112 completed trials (53% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
3.8%
8 terminated out of 213 trials
93.3%
+6.8% vs benchmark
13%
28 trials in Phase 3/4
21%
24 of 112 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 112 completed trials
Clinical Trials (213)
Empowering Preschool Children With Personal Safety Skills
Intrastromal Injection of Fluconazole in Treatment of Fungal Keratitis
Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC
Safety and Efficacy of Distal Radial Access (SAFE-BOX)
Bilateral Peribulbar Block for Cataract Surgery
Korea Comirnaty Post-marketing Surveillance
Evaluating a Shared Decision-making Intervention for Families About Firearm Storage
A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD)
Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer
A Study to Learn More About Prevenar 20 Once it is Out in the Korean Market
Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy
Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis
Cognitive Performance and Mood After Ingestion of Dietary Supplement by University Students
Evaluation of a Sexual Violence and Intimate Partner Violence Primary Prevention Program Implemented in Drinking Establishments
Pharmacokinetics and Safety of a New Micellar Glutathione Formulation
Study to Improve Adolescent Bicycling Safety
A Study of GensSci098 in Subjects With Graves' Disease
A Study of GenSci098 in Subjects With Active Thyroid Eye Disease
Study in Healthy Subjects to Investigate the Relative Bioavailability and Safety of Pasireotide After Single Subcutaneous Dose Administration Using a Reusable ServoPen With Cartridge as Compared to Administration Using a Syringe Drawn From an Ampule
Anti-CD19 CAR-T Cell Therapy in Participants With Moderate to Severe Active Systemic Lupus Erythematosus